Nordic Walking as an Exercise Intervention to Reduce Pain in Women With Aromatase Inhibitor–Associated Arthralgia: A Feasibility Study

Journal of Pain and Symptom Management

Volumn 52, Issue 4, 2016, Pages 548-559

  Fields, Jo ^a,b   Richardson, Alison ^b,c   Hopkinson, Jane ^d   Fenlon, Deborah ^b,c  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

aromatase inhibitor associated arthralgia; breast cancer; exercise; Feasibility trial; joint pain; Nordic walking

Indexed keywords

AROMATASE INHIBITOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ANALGESIA; ARTHRALGIA; ARTICLE; BREAST CANCER; BRIEF PAIN INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPHEDEMA; MIDDLE AGED; NORDIC WALKING; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SAFETY; PHYSICAL ACTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; AGED; BREAST TUMOR; FOLLOW UP; KINESIOTHERAPY; PAIN; PATHOPHYSIOLOGY; PATIENT SATISFACTION; TREATMENT OUTCOME; WALKING;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; EXERCISE THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; TREATMENT OUTCOME; WALKING;

EID: 84994519603     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2016.03.010     Document Type: Article

References (56)

1. 1 Dowsett, M., Cuzick, J, Ingle, J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28 (2010), 509–518.
2. 2 Crew, K.D., et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25 (2007), 3877–3883.
3. 3 Mao, J.J., et al. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115 (2009), 3631–3639.
4. 4 Oberguggenberger, A., et al. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Res Treat 128 (2011), 553–561.
5. 5 Fenlon, D., et al. A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer. J Pain Symptom Manage 46 (2013), 523–535.
6. 6 Fontaine, C., et al. Tolerance of adjuvant letrozole outside of clinical trials. Breast 17 (2008), 376–381.
7. 7 Presant, C.A., et al. Aromatase inhibitor-associated arthralgia and/or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer 7 (2007), 775–778.
8. 8 Sacco, M., et al. Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J Clin Oncol 21 (2003), 2276–2281.
9. 9 Fransen, M., McConnell, S., Land-based exercise for osteoarthritis of the knee: a metaanalysis of randomized controlled trials. J Rheumatol 36 (2009), 1109–1117.
10. 10 Fransen, M., et al. Exercise for osteoarthritis of the hip. Cochrane Database Syst Rev, 2009, CD007912.
11. 11 Hurkmans, E., et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev, 2009, CD006853.
12. 12 Busch, A.J., et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev, 2007, CD003786.
13. 13 Brown, J.C., et al. Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors. Breast J 20 (2014), 22–28.
14. 14 World Health Organization. Global recommendations on physical activity for health. 2010, WHO Press, Switzerland.
15. 15 Schmitz, K.H., et al. American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors. Med Sci Sports Exerc 42 (2010), 1409–1426.
16. 16 Arthritis Research UK. How much exercise should I do and how often. 2014 Available at: http://www.arthritisresearchuk.org/arthritis-information/arthritis-and-daily-life/exercise-and-arthritis/how-much-exercise-should-i-do-and-how-often.aspx Last accessed January 31, 2015.
17. 17 Willson, J., et al. Effects of walking poles on lower extremity gait mechanics. Med Sci Sports Exerc 33 (2001), 142–147.
18. 18 Fregly, B.J., D'Lima, D.D., Colwell, C.W. Jr., Effective gait patterns for offloading the medial compartment of the knee. J Orthop Res 27 (2009), 1016–1021.
19. 19 Rodgers, C.D., VanHeest, J.L., Schachter, C.L., Energy expenditure during submaximal walking with Exerstriders. Med Sci Sports Exerc 27 (1995), 607–611.
20. 20 Schiffer, T., et al. Physiological responses to nordic walking, walking and jogging. Eur J Appl Physiol 98 (2006), 56–61.
21. 21 Malicka, I., et al. The influence of Nordic walking exercise on upper extremity strength and the volume of lymphoedema in women following breast cancer treatment. Isokinetics Exerc Sci 19 (2011), 295–304.
22. 22 Sprod, L.K., et al. The effects of walking poles on shoulder function in breast cancer survivors. Integr Cancer Ther 4 (2005), 287–293.
23. 23 Jonsson, C., Johansson, K., Pole walking for patients with breast cancer-related arm lymphedema. Physiother Theor Pract 25 (2009), 165–173.
24. 24 Craig, P., Petticrew, M., Developing and evaluating complex interventions: reflections on the 2008 MRC guidance. Int J Nurs Stud 50 (2013), 585–587.
25. 25 Borg, G.A., Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982), 377–381.
26. 26 Pollock, M.L., Wilmore, J.H., Exercise in health and disease: evaluation and prescription for prevention and rehabilitation. 2nd ed., 1990, W.B. Saunders, Philadelphia.
27. 27 Macmillan Cancer Support. Get active feel good. My activity diary. 2011 Available at: http://be.macmillan.org.uk/be/p-20037-get-active-feel-good-my-activity-diary.aspx Last accessed January 31, 2015.
28. 28 Department of Health, The General Practice Physical Activity Questionnaire (GPPAQ). A screening tool to assess adult physical activity levels, within primary care. 2009 Available at: http://www.gov.uk Last accessed January 31, 2015.
29. 29 Cleeland, C., The brief pain inventory-user guide. 2009, MD Anderson Centre, Texas.
30. 30 Williams, V.S., Smith, M.Y., Fehnel, S.E., The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage 31 (2006), 48–57.
31. 31 Crew, K.D., et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 28 (2010), 1154–1160.
32. 32 Irwin, M., Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors. 2012 Available at: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=114&abstractID=98367 Last accessed January 31, 2015.
33. 33 Radloff, L., The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977), 385–401.
34. 34 Hann, D., Winter, K., Jacobsen, P., Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46 (1999), 437–443.
35. 35 Nicholas, M.K., Self-efficacy and chronic pain. Paper presented at the annual conference of the British Psychological Society, St. Andrews, Scotland, 1989.
36. 36 Asghari, A., Nicholas, M.K., Pain self-efficacy beliefs and pain behaviour. A prospective study. Pain 94 (2001), 85–100.
37. 37 Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992), 473–483.
38. 38 Moinpour, C.M., et al. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 81 (1989), 485–495.
39. 39 Bowling, A., Measuring disease: a review of disease-specific quality of life measurement scales. 2nd ed., 2001, Open University Press, Buckingham, 395.
40. 40 Mutrie, N., et al. Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ, 334, 2007, 517.
41. 41 Daley, A.J., et al. Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol 25 (2007), 1713–1721.
42. 42 Irwin, M.L., et al. Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study. Cancer 112 (2008), 2593–2606.
43. 43 Cadmus Bertram, L.A., et al. Feasibility of institutional registry-based recruitment for enrolling newly diagnosed breast cancer patients in an exercise trial. J Phys Act Health 8 (2011), 955–963.
44. 44 Penttinen, H., et al. Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible. Contemp Clin Trials 30 (2009), 457–463.
45. 45 Hartvigsen, J., et al. Supervised and non-supervised Nordic walking in the treatment of chronic low back pain: a single blind randomized clinical trial. BMC Musculoskelet Disord, 11, 2010, 30.
46. 46 Mannerkorpi, K., et al. Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Res Ther, 12, 2010, R189.
47. 47 Strombeck, B.E., Theander, E., Jacobsson, L.T., Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome. Rheumatology (Oxford) 46 (2007), 868–871.
48. 48 Husebo, A.M., et al. Predicting exercise adherence in cancer patients and survivors: a systematic review and meta-analysis of motivational and behavioural factors. J Clin Nurs 22 (2013), 4–21.
49. 49 Jordan, J.L., et al. Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev, 2010, CD005956.
50. 50 Jones, L.W., Courneya, K.S., Exercise counseling and programming preferences of cancer survivors. Cancer Pract 10 (2002), 208–215.
51. 51 Rogers, L.Q., et al. Exercise preference patterns, resources, and environment among rural breast cancer survivors. J Rural Health 25 (2009), 388–391.
52. 52 Stevinson, C., et al. Physical activity preferences of ovarian cancer survivors. Psychooncology 18 (2009), 422–428.
53. 53 Nyrop, K.A., et al. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy. J Geriatr Oncol 5 (2014), 148–155.
54. 54 Bravata, D.M., et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 298 (2007), 2296–2304.
55. 55 Farrar, J.T., et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001), 149–158.
56. 56 Irwin, M.L., et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 33 (2015), 1104–1111.